Loading clinical trials...
Loading clinical trials...
A Phase Ib Clinical Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Metastatic Pancreatic Adenocarcinoma
Conditions
Interventions
BBI608
Nab-paclitaxel
+6 more
Locations
12
United States
Mayo Clinic Arizona
Phoenix, Arizona, United States
Emory University Winship Cancer Institute
Atlanta, Georgia, United States
Parkview Research Center
Fort Wayne, Indiana, United States
Indiana University Health Goshen Center for Cancer Care
Goshen, Indiana, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Comprehensive Cancer Centers of Nevada
Henderson, Nevada, United States
Start Date
August 1, 2014
Primary Completion Date
June 1, 2020
Completion Date
June 1, 2020
Last Updated
November 18, 2023
NCT07409272
NCT06998940
NCT06381154
NCT07226856
NCT07344220
NCT01660971
Lead Sponsor
Sumitomo Pharma America, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions